Systemic recalibration and epigenetic resetting as complementary strategies in ageing biology.
Level 5 - mechanism / opinion, no new human data
Narrative review and conceptual perspective paper with no original data.
PubMed 42398771 · doi:10.1016/j.arr.2026.103227
What was done
This perspective critically evaluated two major approaches to aging intervention: systemic circulatory modulation (including heterochronic parabiosis and therapeutic plasma exchange) and cellular epigenetic reprogramming (partial reprogramming via transient expression of Yamanaka factors). The authors reviewed the dilution hypothesis, cell-autonomous aging mechanisms, and proposed an integrated conceptual framework combining both modalities.
What was found
The abstract reports no numerical findings or quantitative effect sizes. It conceptually outlines the limitations of systemic dilution interventions, describes how certain cell populations remain refractory to systemic rejuvenation due to cell-autonomous aging, and posits that combining systemic recalibration with targeted cellular reprogramming warrants future experimental testing.
Why it matters
It provides an integrated theoretical model reconciling systemic and cell-intrinsic aging theories, highlighting the potential need for multimodal therapeutic approaches.
Limits
The paper is a narrative perspective and does not present original experimental or clinical data. The proposed synergistic framework remains theoretical and lacks direct empirical validation in human trials.
Cited by
- supports Yamanaka factors reset the epigenome of differentiated cells.